Our Services

What is Targeted Therapy?

Table of Contents

What are the different types of Targeted Therapy?

Monoclonal antibodies

Monoclonal antibodies are proteins that are designed to attach to specific targets on cancer cells. These antibodies work by marking cancer cells so that they can be identified and destroyed by the immune cells more efficiently. Some monoclonal antibodies attack cancer cells directly and prevent their growth or cause the cancer cells to self-destruct.

Small-molecule drugs

Drugs called small-molecule drugs can block the process that helps cancer cells multiply and spread.

What is the difference between Chemotherapy, Targeted Therapy and Immunotherapy?

Difference between Chemotherapy, Targeted Therapy and Immunotherapy
Difference between Chemotherapy, Targeted Therapy and Immunotherapy.mobile

While chemotherapy and targeted therapy are both effective methods of cancer therapy, the key difference is that chemotherapy can also kill healthy cells when eliminating cancer cells. Whereas targeted therapy preferentially targets and attacks the cancer cells, allowing the survival of healthy cells.

How does Targeted Therapy work against cancer?

Targeted therapy works by altering the functions of the cancer cell, particularly on the part of the cell that makes it different from any other healthy cell. Targeted therapy interferes with the action of specific proteins that help the cancer cells to grow and spread to other organs. They work in different ways including:

  • Helping the immune system seek out and destroy cancer cells – Targeted therapy can mark the specific cancer cells making it easier for the immune system to identify and destroy them. At the same time, it boosts the functions and ability of the immune system to fight against cancer.
  • Blocking signals to slow down cancer cells’ growth – Targeted therapy blocks and turns of signals that tell cancer cells to grow and divide.
  • Stopping the development of blood vessels that feed the cancer cells – Cancer cells require a constant supply of nutrients and oxygen in order to grow and divide. Targeted therapies like angiogenesis inhibitors interfere with this growth process by preventing the formation of new blood vessels.
  • Delivering toxins directly to the cancer cells – Some monoclonal antibodies attach to specific targets on the surface of cancer cells and destroy them. Cells that do not have the target will not be harmed.

How is Targeted Therapy administered?

Targeted therapy can be administered orally or by injection intramuscularly (into the muscle), subcutaneously (under the skin), or intravenously (through the vein).

The dose, frequency, and duration of targeted therapy vary depending on the type of cancer. Some patients are prescribed daily dosing of these medications while some patients need to follow a monthly dosing schedule.

Examples of Blood Cancers which may benefit from Targeted Therapy:

Most cases of chronic myeloid leukaemia are caused by a gene called BCR-ABL. This gene leads to the production of an enzyme called the BCR-ABL protein which causes normal myeloid cells to start behaving like cancer cells. This was the first cancer to be treated with targeted therapy.

In lymphoma, there is an overproduction of B cells which is a white blood cell that fights infections.  Targeted therapy drugs block the enzyme that leads to this overproduction of B cells.

What are the side effects of Targeted Therapy?

The side effects of targeted therapy drugs are generally well tolerated in comparison to those of conventional chemotherapy. Side effects depend primarily on the type of drug that is given and what it targets. 

The commonly reported side effects include:

  1. Fatigue
  2. Diarrhoea
  3. Reduced appetite
  4. Skin rashes
  5. Abnormal changes in smell or taste
  6. Sensory abnormalities
  7. Blood tests abnormalities

 

The commonly reported side effects include:

Targeted Therapy at CFCH

At CFCH, our haematologists will tailor your treatment regimen based on the latest guidance and research as well as their extensive experience.  You will be monitored closely during your course of treatment for side effects, and tests are done to assess how you are responding to treatment.  Our doctors and team of nurses strive to ensure that you are fully involved and informed of your treatment and that you are as comfortable as possible during your treatment period.

Related Articles and Media

Disclaimer:

The information on the Centre For Clinical Haematology website is intended for educational use. It should not be considered or used as a substitute for medical advice, diagnosis or treatment from a qualified health professional.

Insurance Partners

We Partner With Leading Insurance Providers

We partner with major insurance providers in Singapore to streamline the financial process, allowing you to focus on what truly matters: your recovery. Contact our team for more information and support.

Patient Journey

Caring for you, every step of the way

The CFCH team is committed to providing patient-centred care and comprehensive multidisciplinary support through every stage of your journey with us.

Meet with Our Doctor

During your initial consultation, you'll meet our doctors who will listen to your concerns and begin your evaluation and recommend the necessary investigations required.

Planning Your Care

After diagnosis, we will plan your care, tailoring treatment options to your unique needs for the optimal outcome.

Treatment Monitoring

Throughout your treatment journey, we will provide a supportive environment to closely monitor your progress, ensuring your comfort and adjusting care as needed.

Long-term Support

After treatment, we will continue to support you with a holistic approach to your recovery, to ensure that both your physical and mental wellbeing are looked after.